Work

High-Intensity Statins in Acute Coronary Syndrome Part 1: A look at the pharmacological properties of Statins and clinical trials on Statins in ACS

Year: 2023
Type: article
Abstract: Acute coronary syndrome (ACS) is a term that encompasses a range of conditions associated with sudden, reduced blood flow to the heart. These conditions can range from unstable angina to myocardial infarction. Over the years, various therapeutic agents have been utilized to manage ACS and improve clinical outcomes. One of the mainstays of therapy for ACS has been the class of medications known as statins. We discuss the role of statins in ACS, their mechanism of action, clinical evidence supporting their use, and the potential future directions in this area. This critical period post-ACS underscores the necessity for effective interventions to mitigate further risks. Among the therapeutic options available, statins play a pivotal role. These medications, when administered soon after an ACS event, offer significant benefits. Statins have the potential to stabilize atherosclerotic plaques, reduce the lipid component of these plaques, and decrease inflammation—all of which contribute to reducing the risk of subsequent cardiac events. Given the elevated risk immediately after an ACS event, initiating statin therapy as early as possible is imperative to ensure the maximum reduction in potential adverse outcomes. The timely introduction of statins can thus provide pronounced benefits during the period when the patient's risk is at its peak.
Authors: Mukesh Kumar, Utsav Anand Mani, Haider Abbas, Pranay Gupta
Language: English
Field: Medicine
Open Access status: diamond
OpenAlex ID: W4391237758
FWCI: 1.127
Cites: 47
Cited by: 7
Related to: 10